ITTO20040760A1 - USE OF A CORTICOSTEROID IN ASSOCIATION WITH OTHER ACTIVE PRINCIPLES FOR THE TREATMENT OF VASCULAR STENOSIS AND THE PREVENTION OF VASCULAR RESTENOSIS - Google Patents
USE OF A CORTICOSTEROID IN ASSOCIATION WITH OTHER ACTIVE PRINCIPLES FOR THE TREATMENT OF VASCULAR STENOSIS AND THE PREVENTION OF VASCULAR RESTENOSISInfo
- Publication number
- ITTO20040760A1 ITTO20040760A1 IT000760A ITTO20040760A ITTO20040760A1 IT TO20040760 A1 ITTO20040760 A1 IT TO20040760A1 IT 000760 A IT000760 A IT 000760A IT TO20040760 A ITTO20040760 A IT TO20040760A IT TO20040760 A1 ITTO20040760 A1 IT TO20040760A1
- Authority
- IT
- Italy
- Prior art keywords
- vascular
- corticosteroid
- association
- prevention
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT000760A ITTO20040760A1 (en) | 2004-11-03 | 2004-11-03 | USE OF A CORTICOSTEROID IN ASSOCIATION WITH OTHER ACTIVE PRINCIPLES FOR THE TREATMENT OF VASCULAR STENOSIS AND THE PREVENTION OF VASCULAR RESTENOSIS |
BRPI0517983-1A BRPI0517983A (en) | 2004-11-03 | 2005-11-02 | corticosteroid use in combination with diuretic and antacid for treatment of vascular stenosis and prevention of vascular restenosis |
CA002586212A CA2586212A1 (en) | 2004-11-03 | 2005-11-02 | Use of a corticosteroid in association with a diuretic and an antacid for the treatment of vascular stenosis and the prevention of vascular restenosis |
PCT/IB2005/003271 WO2006048736A1 (en) | 2004-11-03 | 2005-11-02 | Use of a corticosteroid in association with a diuretic and an antacid for the treatment of vascular stenosis and the prevention of vascular restenosis |
EP05809315A EP1814557A1 (en) | 2004-11-03 | 2005-11-02 | Use of a corticosteroid in association with a diuretic and an antacid for the treatment of vascular stenosis and the prevention of vascular restenosis |
RU2007120522/14A RU2007120522A (en) | 2004-11-03 | 2005-11-02 | USE OF A CORTICOSTEROID IN COMBINATION WITH DIURETIC AND ANTACID FOR THE TREATMENT OF VASCULAR STENOSIS AND PREVENTION OF VASCULAR RESTENOSIS |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT000760A ITTO20040760A1 (en) | 2004-11-03 | 2004-11-03 | USE OF A CORTICOSTEROID IN ASSOCIATION WITH OTHER ACTIVE PRINCIPLES FOR THE TREATMENT OF VASCULAR STENOSIS AND THE PREVENTION OF VASCULAR RESTENOSIS |
Publications (1)
Publication Number | Publication Date |
---|---|
ITTO20040760A1 true ITTO20040760A1 (en) | 2005-02-03 |
Family
ID=36051437
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT000760A ITTO20040760A1 (en) | 2004-11-03 | 2004-11-03 | USE OF A CORTICOSTEROID IN ASSOCIATION WITH OTHER ACTIVE PRINCIPLES FOR THE TREATMENT OF VASCULAR STENOSIS AND THE PREVENTION OF VASCULAR RESTENOSIS |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1814557A1 (en) |
BR (1) | BRPI0517983A (en) |
CA (1) | CA2586212A1 (en) |
IT (1) | ITTO20040760A1 (en) |
RU (1) | RU2007120522A (en) |
WO (1) | WO2006048736A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
US8324192B2 (en) | 2005-11-12 | 2012-12-04 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
US8679545B2 (en) | 2005-11-12 | 2014-03-25 | The Regents Of The University Of California | Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract |
US20090143343A1 (en) | 2007-11-13 | 2009-06-04 | Meritage Pharma, Inc. | Compositions for the treatment of inflammation of the gastrointestinal tract |
SI2211896T1 (en) | 2007-11-13 | 2018-04-30 | Meritage Pharma, Inc. | Compositions for the treatment of gastrointestinal inflammation |
EP2127639A1 (en) * | 2008-05-26 | 2009-12-02 | Universiteit Utrecht Holding B.V. | Corticosteroid containing liposomes for treatment of cardiovascular diseases |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6500938B1 (en) * | 1998-01-30 | 2002-12-31 | Incyte Genomics, Inc. | Composition for the detection of signaling pathway gene expression |
JP2003530343A (en) * | 2000-04-12 | 2003-10-14 | ノバルティス アクチエンゲゼルシャフト | Novel pharmaceutical use of aldosterone synthase inhibitor alone or in combination with AT1-receptor antagonist |
-
2004
- 2004-11-03 IT IT000760A patent/ITTO20040760A1/en unknown
-
2005
- 2005-11-02 CA CA002586212A patent/CA2586212A1/en not_active Abandoned
- 2005-11-02 BR BRPI0517983-1A patent/BRPI0517983A/en not_active Application Discontinuation
- 2005-11-02 WO PCT/IB2005/003271 patent/WO2006048736A1/en active Application Filing
- 2005-11-02 EP EP05809315A patent/EP1814557A1/en not_active Withdrawn
- 2005-11-02 RU RU2007120522/14A patent/RU2007120522A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
BRPI0517983A (en) | 2008-10-21 |
EP1814557A1 (en) | 2007-08-08 |
WO2006048736A1 (en) | 2006-05-11 |
RU2007120522A (en) | 2008-12-10 |
CA2586212A1 (en) | 2006-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SI1830816T1 (en) | Solid dosage form comprising proton pump inhibitor and suspension made thereof | |
DK1150678T3 (en) | Use of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in the manufacture of a medicament for the treatment of diabetic neuropathy | |
PL1830888T3 (en) | Lipid complexes coated with peg and their use | |
WO2006097535A3 (en) | Peptide agonists of the glucagon family with secretin like activity | |
CA113972S (en) | Track for display shelving | |
ATE553096T1 (en) | PYRIDAZINE DERIVATIVES AND THEIR USE AS THERAPEUTIC ACTIVE INGREDIENTS | |
CA112175S (en) | Dispenser | |
IL166522A0 (en) | Combination of zd6474 an inhibitor of the vascularendothelial growth factor receptor with radiother apy in the treatment of cancer | |
ITRM20050103A1 (en) | ASSOCIATION OF ANTAGONISTS OF THE INTERLEUCHINE 6 AND ANTIPROLIFERATIVE DRUGS. | |
WO2006017822A3 (en) | Quinazoline derivatives and their use in the treatment of thrombocythemia | |
DE60317192D1 (en) | WITH TOTGANG AND TWO DISCS SITTING AMPLIFIERS | |
SI1807156T1 (en) | New pharmaceutical formulations useful in the treatment of insomnia | |
DE602004029308D1 (en) | Stents and stent delivery systems | |
ITTO20040760A1 (en) | USE OF A CORTICOSTEROID IN ASSOCIATION WITH OTHER ACTIVE PRINCIPLES FOR THE TREATMENT OF VASCULAR STENOSIS AND THE PREVENTION OF VASCULAR RESTENOSIS | |
EP1726313A4 (en) | Drug for preventing and treating arteriosclerosis | |
WO2007086943A3 (en) | Wortmannin conjugates and uses thereof | |
CA115335S (en) | Massage chair | |
CA115340S (en) | Massage chair | |
CA115336S (en) | Massage chair | |
ITRM20040607A1 (en) | ANALOGUES OF THE DERMORFINA WITH ANALGESIC ACTIVITY. | |
EP1956029A4 (en) | Vascular aging-predicting factor and utilization of the same | |
ITTO20040460A1 (en) | ABSORBENT WEARABLE SANITARY PRODUCTS IN THE WAY OF A PUT AND RELATED MANUFACTURING PROCEDURE. | |
ITMO20040175A1 (en) | DEVICE FOR THE INTRODUCTION AND POSITIONING OF STENTS IN VANGI SANGUGNI. | |
AU2003244437A1 (en) | Quinoxalinones and their use especially in the treatment of cardiovascular diseases | |
NO20022747L (en) | treatment chair |